Eric Benevich

Eric Benevich is the Chief Commercial Officer at Neurocrine Biosciences. Eric has over 25 years of experience in the pharmaceutical industry, including roles at Astra Merck, AstraZeneca, Amgen, and Peninsula Pharmaceuticals. Eric has a proven track record in sales and marketing, and has been instrumental in the success of several life-changing pharmaceuticals. Eric is passionate about their work and is committed to making a difference in the lives of patients with neurological and endocrine diseases.

Eric Benevich has a Bachelor of Science in International Business from Washington State University. Eric is currently enrolled in a DIS program at Københavns Universitet - University of Copenhagen.

Eric Benevich reports to Kevin C. Gorman, CEO. They work with Jude Onyia - Chief Scientific Officer, Eiry W. Roberts - Chief Medical Officer, and Kyle W. Gano - Chief Business Development & Strategy Officer.